Cargando…

Histone Signatures Predict Therapeutic Efficacy in Breast Cancer

Objective: Regulatory abnormalities caused by chromatin modifications are being increasingly recognized as contributors to cancer. While many molecularly targeted drugs have the potential to revert these modifications, their precise mechanism of action in cellular reprogramming is not known. Methods...

Descripción completa

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	IEEE 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7207876/ https://www.ncbi.nlm.nih.gov/pubmed/32412527 http://dx.doi.org/10.1109/OJEMB.2020.2967105

Ejemplares similares

Histone 3 Lysine 27 Trimethylation Signature in Breast Cancer
por: Borkiewicz, Lidia
Publicado: (2021)

TRIM24 links a noncanonical histone signature to breast cancer
por: Tsai, Wen-Wei, et al.
Publicado: (2010)

Expression and potential prognostic value of histone family gene signature in breast cancer
por: Xie, Wenting, et al.
Publicado: (2019)

A Histone Acetylation Modulator Gene Signature for Classification and Prognosis of Breast Cancer
por: Long, Mengping, et al.
Publicado: (2021)

DNA Methylation Signatures Predicting Bevacizumab Efficacy in Metastatic Breast Cancer
por: Gampenrieder, Simon Peter, et al.
Publicado: (2018)

Identification of a histone family gene signature for predicting the prognosis of cervical cancer patients
por: Li, Xiaofang, et al.
Publicado: (2017)

Chromatin Regulator-Related Gene Signature for Predicting Prognosis and Immunotherapy Efficacy in Breast Cancer
por: Feng, Dongxu, et al.
Publicado: (2023)

Therapeutic Strategies to Enhance the Anticancer Efficacy of Histone Deacetylase Inhibitors
por: Miller, Claudia P., et al.
Publicado: (2011)

Construction and Validation of an Immune Infiltration-Related Gene Signature for the Prediction of Prognosis and Therapeutic Response in Breast Cancer
por: Peng, Yang, et al.
Publicado: (2021)

Development and Validation of a Novel Histone Acetylation-Related Gene Signature for Predicting the Prognosis of Ovarian Cancer
por: Dai, Qinjin, et al.
Publicado: (2022)

Establishment, immunological analysis, and drug prediction of a prognostic signature of ovarian cancer related to histone acetylation
por: Fang, Yujie, et al.
Publicado: (2022)

Identification of CircRNA signature associated with tumor immune infiltration to predict therapeutic efficacy of immunotherapy
por: Dong, Yu, et al.
Publicado: (2023)

Prognosis and Therapeutic Efficacy Prediction of Adrenocortical Carcinoma Based on a Necroptosis-Associated Gene Signature
por: Ji, Dan, et al.
Publicado: (2022)

Control of Breast Cancer Pathogenesis by Histone Methylation and the Hairless Histone Demethylase
por: Trager, Megan H, et al.
Publicado: (2021)

Pyroptosis-Related Signatures for Predicting Prognosis in Breast Cancer
por: Ren, Tong, et al.
Publicado: (2022)

Sequence-dependent histone variant positioning signatures
por: Le, Ngoc Tu, et al.
Publicado: (2010)

Predicting therapeutic efficacy of endocrine therapy for stage IV breast cancer by tumor-infiltrating lymphocytes
por: Asano, Yuka, et al.
Publicado: (2020)

Combining Gene Signatures Improves Prediction of Breast Cancer Survival
por: Zhao, Xi, et al.
Publicado: (2011)

Establishing a Novel Gene Signature Related to Histone Modifications for Predicting Prognosis in Lung Adenocarcinoma
por: Liu, Mengfeng, et al.
Publicado: (2022)

A novel signature based on cancer-associated fibroblast genes to predict prognosis, immune feature, and therapeutic response in breast cancer
por: Wang, Yichen, et al.
Publicado: (2023)

Efficacy and Safety Profile of Histone Deacetylase Inhibitors for Metastatic Breast Cancer: A Meta-Analysis
por: Wang, Changjun, et al.
Publicado: (2022)

Myeloid cell signatures in tumor microenvironment predicts therapeutic response in cancer
por: Achyut, Bhagelu R, et al.
Publicado: (2016)

A ferroptosis-associated gene signature for the prediction of prognosis and therapeutic response in luminal-type breast carcinoma
por: Peng, Yang, et al.
Publicado: (2021)

Stemness signature and targeted therapeutic drugs identification for Triple Negative Breast Cancer
por: Gul, Samina, et al.
Publicado: (2023)

Histone Deacetylase Functions in Gastric Cancer: Therapeutic Target?
por: Badie, Amandine, et al.
Publicado: (2022)

An immune‐related prognostic signature for predicting breast cancer recurrence
por: Tian, Zelin, et al.
Publicado: (2020)

A Metabolic Gene Signature to Predict Breast Cancer Prognosis
por: Lu, Jun, et al.
Publicado: (2022)

Histone modification and histone modification-targeted anti-cancer drugs in breast cancer: Fundamentals and beyond
por: Feng, Jianwei, et al.
Publicado: (2022)

Stemness-related gene signature for predicting therapeutic response in patients with esophageal cancer
por: Zhu, Shaojin, et al.
Publicado: (2022)

A quantitative atlas of histone modification signatures from human cancer cells
por: LeRoy, Gary, et al.
Publicado: (2013)

Identifying a miRNA signature for predicting the stage of breast cancer
por: Yerukala Sathipati, Srinivasulu, et al.
Publicado: (2018)

Oncogene-mediated metabolic gene signature predicts breast cancer outcome
por: Aslan, Merve, et al.
Publicado: (2021)

Histone H1 Phosphorylation in Breast Cancer
por: Harshman, Sean W., et al.
Publicado: (2014)

Histone demethylase GASC1 - a potential prognostic and predictive marker in invasive breast cancer
por: Berdel, Bozena, et al.
Publicado: (2012)

Developing ZNF Gene Signatures Predicting Radiosensitivity of Patients with Breast Cancer
por: Yan, Derui, et al.
Publicado: (2021)

Efficacy of Histone Deacetylase and Estrogen Receptor Inhibition in Breast Cancer Cells Due to Concerted down Regulation of Akt
por: Thomas, Scott, et al.
Publicado: (2013)

HIPPO signaling-related signature for predicting prognosis and therapeutic response in gastric cancer
por: Jiang, Rui, et al.
Publicado: (2023)

An Immune Signature for Risk Stratification and Therapeutic Prediction in Helicobacter pylori-Infected Gastric Cancer
por: Geng, Haigang, et al.
Publicado: (2022)

Heterocellular gene signatures reveal luminal-A breast cancer heterogeneity and differential therapeutic responses
por: Poudel, Pawan, et al.
Publicado: (2019)

Histone Deacetylase as a Valuable Predictive Biomarker and Therapeutic Target in Immunotherapy for Non–Small Cell Lung Cancer
por: Shin, Hyun-Seock, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_umkvt34shcqf61lt4qgk37fsmn